导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.03% | 369/1259 |
| 近一周 | 0.20% | 225/1304 |
| 近一月 | -0.63% | 879/1302 |
| 近一季 | 0.60% | 347/1288 |
| 近半年 | 6.65% | 227/1283 |
| 近一年 | 6.98% | 396/1253 |
| 近两年 | 15.63% | 300/1200 |
| 近三年 | 9.09% | 640/1072 |
| 成立以来 | 3.14% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.36% 644/1341 |
-0.28% 1282/1366 |
8.19% 159/1361 |
- - |
| 2024 | 7.15% 349/1373 |
3.76% 53/1403 |
2.05% 209/1402 |
0.34% 1182/1374 |
0.85% 853/1373 |
| 2023 | -4.97% 1126/1401 |
-1.45% 1307/1367 |
-3.26% 1302/1388 |
-0.88% 712/1403 |
0.56% 160/1401 |
| 2022 | -6.16% 886/1336 |
-8.87% 1045/1128 |
5.44% 55/1307 |
-4.24% 1136/1325 |
1.98% 76/1336 |
| 2021 | -2.06% 598/1165 |
-0.90% 485/633 |
0.62% 558/921 |
-3.97% 883/1070 |
2.28% 324/1163 |
| 2020 | - - |
- - |
- - |
- - |
2.56% 436/675 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 汇添富稳健收益混合A VS. () |